Neuraxis, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.3% | +21.7% | -5.4% | +9.0% | +14.2% | +17.7% | -0.2% | -9.2% | +19.3% | +66.1% | +20.0% | – | |
| – | +7.5% | +3.8% | -2.2% | +32.1% | +8.2% | +32.8% | +5.1% | -7.6% | +4.3% | +54.5% | +24.8% | – | |
| – | +11.9% | +24.5% | -5.9% | +5.9% | +15.2% | +15.3% | -1.2% | -9.6% | +22.3% | +68.1% | +19.2% | – | |
| – | -95.1% | +150.8% | +875.1% | +33.3% | +1.9% | -17.9% | -3.7% | +124.4% | +86.4% | -59.2% | +175.5% | – | |
| – | -39.5% | +15.2% | +13.4% | -21.9% | -5.0% | +46.5% | -20.7% | -16.9% | -43.8% | +108.4% | +19.9% | – | |
| – | -39.3% | +15.4% | +14.2% | -19.1% | -4.4% | +43.7% | -19.2% | +12.6% | -8.4% | +23.1% | +20.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.4% | +114.0% | +199.6% | -27.0% | -97.7% | -6.6% | +500.5% | +120.8% | -3.5% | -8.5% | -24.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.3% | +0.0% | -1,828.1% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.